T cell immunity is central for the control of viral infections. To characterize T cell immunity,
but also for the development of vaccines, identification of exact viral T cell epitopes is …

T cell immunity is central for the control of viral infections. CoVac-1 is a peptide-based vaccine
candidate, composed of SARS-CoV-2 T cell epitopes derived from various viral proteins 1 …

Long-term immunological memory to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
is crucial for the development of population-level immunity, which is the aim of …

The quality and persistence of children’s humoral immune response following SARS-CoV-2
infection remains largely unknown but will be crucial to guide pediatric SARS-CoV-2 …

Several COVID-19 vaccines are approved to prevent severe disease outcome after SARS-CoV-2
infection. Whereas induction and functionality of antiviral antibody response are largely …

T-cell immunity is central for control of COVID-19, particularly in patients incapable of mounting
antibody responses. CoVac-1 is a peptide-based T-cell activator composed of SARS-CoV…

CCL2, also referred to as MCP-1, is critically involved in directing the migration of blood
monocytes to sites of inflammation. Consequently, excessive CCL2 secretion has been linked to …

The humoral immune response to SARS-CoV-2 is a benchmark for immunity and detailed
analysis is required to understand the manifestation and progression of COVID-19, monitor …

Objectives Serological assays for detection of SARS-CoV-2 antibodies are increasingly used
during the COVID-19 pandemic caused by the SARS-Coronavirus-2. Here we evaluated …

This first comprehensive analysis of SARS-CoV-2 immune responses in patients with
cancer reports on the potential implications of impaired SARS-CoV-2 T-cell responses for …